Labeling of Meat or Poultry Products Comprised of or Containing Cultured Animal Cells, 49491-49496 [2021-19057]
Download as PDF
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
In appropriate circumstances, when
compliance would not appear to
interfere with or adversely affect the law
enforcement purposes of this system
and the overall law enforcement
process, the applicable exemptions may
be waived on a case-by-case basis.
A system of records notice for DHS/
OIDO–001 Office of the Immigration
Detention Ombudsman System of
Records is also published in this issue
of the Federal Register.
List of Subjects in 6 CFR Part 5
Freedom of information; Privacy.
For the reasons stated in the
preamble, DHS proposes to amend
chapter I of title 6, Code of Federal
Regulations, as follows:
PART 5—DISCLOSURE OF RECORDS
AND INFORMATION
1. The authority citation for part 5
continues to read as follows:
■
Authority: 6 U.S.C. 101 et seq.; Pub. L.
107–296, 116 Stat. 2135; 5 U.S.C. 301.
Subpart A also issued under 5 U.S.C. 552.
Subpart B also issued under 5 U.S.C. 552a.
2. In appendix C to part 5, add
paragraph 86 to read as follows:
■
Appendix C to Part 5—DHS Systems of
Records Exempt From the Privacy Act
lotter on DSK11XQN23PROD with PROPOSALS1
*
*
*
*
*
86. The DHS/OIDO–001 Office of the
Immigration Detention Ombudsman System
of Records consists of electronic and paper
records and will be used by DHS and its
components. The DHS/OIDO–001 Office of
the Immigration Detention Ombudsman
System of Records is a repository of
information held by DHS in connection with
its several and varied missions and functions,
including, but not limited to the enforcement
of civil and criminal laws, and investigations,
inquiries, and proceedings there under. The
DHS/OIDO–001 Office of the Immigration
Detention Ombudsman System of Records
contains information that is collected by, on
behalf of, in support of, or in cooperation
with DHS and its components and may
contain personally identifiable information
collected by other federal, state, local, tribal,
foreign, or international government
agencies.
The Secretary of Homeland Security,
pursuant to 5 U.S.C. 552a(k)(2) and (k)(5), has
exempted this system from the following
provisions of the Privacy Act: 5 U.S.C.
552a(c)(3); (d); (e)(1), (e)(4)(G), (e)(4)(H),
(e)(4)(I); and (f). Where a record received
from another system has been exempted in
that source system under 5 U.S.C. 552a(j)(2),
(k)(2), or (k)(5), DHS will claim the same
exemptions for those records that are claimed
for the original primary systems of records
from which they originated and claims any
additional exemptions set forth here.
Exemptions from these particular
subsections are justified, on a case-by-case
basis to be determined at the time a request
is made, for the following reasons:
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
(a) From subsection (c)(3) (Accounting for
Disclosures) because release of the
accounting of disclosures could alert the
subject of an investigation of an actual or
potential criminal, civil, or regulatory
violation to the existence of that investigation
and reveal investigative interest on the part
of DHS as well as the recipient agency.
Disclosure of the accounting would therefore
present a serious impediment to law
enforcement efforts and efforts to preserve
national security. Disclosure of the
accounting would also permit the individual
who is the subject of a record to impede the
investigation, to tamper with witnesses or
evidence, and to avoid detection or
apprehension, which would undermine the
entire investigative process. When an
investigation has been completed,
information on disclosures made may
continue to be exempted if the fact that an
investigation occurred remains sensitive after
completion.
(b) From subsection (d) (Access and
Amendment to Records) because access to
the records contained in this system of
records could inform the subject of an
investigation of an actual or potential
criminal, civil, or regulatory violation to the
existence of that investigation and reveal
investigative interest on the part of DHS or
another agency. Access to the records could
permit the individual who is the subject of
a record to impede the investigation, to
tamper with witnesses or evidence, and to
avoid detection or apprehension.
Amendment of the records could interfere
with ongoing investigations and law
enforcement activities. Further, permitting
amendment to counterintelligence records
after an investigation has been completed
would impose an unmanageable
administrative burden. In addition,
permitting access and amendment to such
information could disclose security-sensitive
information that could be detrimental to
homeland security.
(c) From subsection (e)(1) (Relevancy and
Necessity of Information) because in the
course of investigations into potential
violations of federal law, the accuracy of
information obtained or introduced
occasionally may be unclear, or the
information may not be strictly relevant or
necessary to a specific investigation. In the
interests of effective law enforcement, it is
appropriate to retain all information that may
aid in establishing patterns of unlawful
activity.
(d) From subsections (e)(4)(G), (e)(4)(H),
and (e)(4)(I) (Agency Requirements) and (f)
(Agency Rules), because portions of this
system are exempt from the individual access
provisions of subsection (d) for the reasons
noted above, and therefore DHS is not
required to establish requirements, rules, or
procedures with respect to such access.
Providing notice to individuals with respect
to existence of records pertaining to them in
the system of records or otherwise setting up
procedures pursuant to which individuals
may access and view records pertaining to
themselves in the system would undermine
investigative efforts and reveal the identities
PO 00000
Frm 00002
Fmt 4702
Sfmt 4702
49491
of witnesses, and potential witnesses, and
confidential informants.
Lynn Parker Dupree,
Chief Privacy Officer, U.S. Department of
Homeland Security.
[FR Doc. 2021–18797 Filed 9–2–21; 8:45 am]
BILLING CODE 9112–AS–P
DEPARTMENT OF AGRICULTURE
Food Safety and Inspection Service
9 CFR Chapter III
[Docket No. FSIS–2020–0036]
RIN 0583–AD89
Labeling of Meat or Poultry Products
Comprised of or Containing Cultured
Animal Cells
Food Safety and Inspection
Service, USDA.
ACTION: Advance notice of proposed
rulemaking.
AGENCY:
The Food Safety and
Inspection Service (FSIS) is publishing
this advance notice of proposed
rulemaking (ANPR) to request
comments pertaining to the labeling of
meat and poultry products comprised of
or containing cultured cells derived
from animals subject to the Federal
Meat Inspection Act or the Poultry
Products Inspection Act. Issues raised in
the comments submitted in response to
this ANPR will inform future
rulemaking to establish labeling
requirements for these products. This
ANPR also discusses how FSIS will
generally evaluate labels for these
products if they are submitted before the
Agency completes rulemaking.
DATES: Submit comments on or before
November 2, 2021.
ADDRESSES: FSIS invites interested
persons to submit comments on this
document. Comments may be submitted
by one of the following methods:
• Federal eRulemaking Portal: This
website provides the ability to type
short comments directly into the
comment field on this web page or
attach a file for lengthier comments. Go
to https://www.regulations.gov. Follow
the on-line instructions at that site for
submitting comments.
• Mail: Send to Docket Clerk, U.S.
Department of Agriculture, Food Safety
and Inspection Service, 1400
Independence Avenue SW, Mailstop
3758, Washington, DC 20250–3700.
• Hand- or courier-delivered
submittals: Deliver to 1400
Independence Avenue SW, Jamie L.
Whitten Building, Room 350–E,
Washington, DC 20250–3700.
SUMMARY:
E:\FR\FM\03SEP1.SGM
03SEP1
49492
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
lotter on DSK11XQN23PROD with PROPOSALS1
Instructions: All items submitted by
mail or electronic mail must include the
Agency name and docket number FSIS–
2020–0036. Comments received in
response to this docket will be made
available for public inspection and
posted without change, including any
personal information, to https://
www.regulations.gov.
Docket: For access to background
documents or comments received, call
(202) 720–5627 to schedule a time to
visit the FSIS Docket Room at 1400
Independence Avenue SW, Washington,
DC 20250–3700.
FOR FURTHER INFORMATION CONTACT:
Rachel Edelstein, Assistant
Administrator, Office of Policy and
Program Development by telephone at
(202) 205–0495.
SUPPLEMENTARY INFORMATION:
I. Background
This ANPR concerns the labeling of
meat and poultry products produced
using animal cell culture technology,
including how these products are to be
identified and described specifically in
regard to their nature, source, or
characteristics. Animal cell culture
technology is a process that involves
taking a small number of cells from
living animals and growing them in a
controlled environment to create food,
among other things. Scientists typically
start with a sample of cells from the
tissue of an animal, some of which are
selected, screened, and stored for future
use. Later, some of these stored cells are
retrieved and placed in a controlled
environment with appropriate nutrients
and other factors to support growth and
cellular multiplication. After the cells
have multiplied, additional inputs such
as growth factors, new surfaces for cell
attachment, and additional nutrients are
added to the controlled environment to
enable the cells to differentiate into
various cell types. Once produced, the
harvested cells can be processed,
packaged, and marketed in the same, or
similar, manner as slaughtered 1 meat
and poultry products. This ANPR refers
to such foods as ‘‘cultured’’ meat and
poultry products or as products
compromised of or containing
‘‘cultured’’ animal cells. The use of this
term, however, is not intended to
establish or suggest nomenclature for
labeling purposes.
Many companies, both domestic and
foreign, are currently developing
cultured products derived from the cells
of food animals amenable to the Federal
Meat Inspection Act (FMIA; 21 U.S.C.
1 This ANPR refers to all meat or poultry products
not produced using animal cell culture technology
as ‘‘slaughtered’’ meat and poultry products.
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
601 et. seq.) (cattle, sheep, swine, goats,
and fish of the order Siluriformes, e.g.,
catfish) or the Poultry Products
Inspection Act (PPIA; 21 U.S.C. 451 et
seq.) (chickens, turkeys, ducks, geese,
guineas, ratites, and squabs). Human
food products derived from these
species (hereinafter ‘‘meat and poultry
products’’) fall under FSIS jurisdiction.
Under the FMIA and PPIA (hereinafter
‘‘the Acts’’), FSIS regulates the labeling
of all meat and poultry products under
its jurisdiction to ensure such products
are not misbranded (21 U.S.C. 607(d)
and 457(c)). FSIS is now seeking
comments to inform future regulatory
requirements for the labeling of cultured
meat and poultry products intended to
prevent misbranding.
A. FSIS Authority Over the Labeling of
Cultured Meat and Poultry Products
FSIS is the federal agency that, under
the authority of the Acts, protects public
health by ensuring that meat and
poultry products are wholesome, not
adulterated, and properly marked,
labeled, and packaged. To that end,
FSIS issues and enforces federal
regulations to ensure, among other
things, that meat and poultry products
in commerce within the United States
are not misbranded (21 U.S.C. 607(d)
and 457(c)). With limited exceptions,
U.S. states or territories may not impose
requirements within the scope of the
Acts—such as labeling requirements—
that are in addition to, or different from,
the requirements established by the Acts
or their implementing regulations (21
U.S.C. 678 and 476e).
B. Relevant Misbranding Provisions
Under the Acts
Under the Acts, a meat or poultry
product is misbranded under a number
of circumstances. In general, it is
misbranded if its labeling is false or
misleading in any particular (21 U.S.C.
601(n)(1) and 453(h)(1)). It is also
misbranded if it is offered for sale under
the name of another food (21 U.S.C.
601(n)(2) and 453(h)(2)) or if it is an
imitation of another food, but not
labeled as such (21 U.S.C. 601(n)(3) and
453 (h)(3)).
A product is also misbranded if it
purports to be or is represented as a
food for which a standard of identity
has been prescribed, without
conforming to the standard (21 U.S.C.
601(n)(7) and 453(h)(7)). FSIS has
authority to establish standards of
identity for meat and poultry products
to help ensure such products have the
characteristics expected by consumers
(21 U.S.C. 607(c) and 457(b)). Standards
of identity establish specific names,
terms, and information to be used on
PO 00000
Frm 00003
Fmt 4702
Sfmt 4702
product labels. Standards may also
require the presence of certain expected
ingredients in products, regulate the
minimum or maximum amount of
ingredients in products, or specify how
products are formulated, processed, or
prepared.
If a product is not covered by a
standard of identity, it is misbranded
unless its label bears the common or
usual name of the food, if there is one,
and the common or usual name of its
ingredients (21 U.S.C. 601(n)(9) and
453(h)(9)). Common or usual names are
generally established by common usage
but, in some cases, they may be
established by regulation. In the absence
of either a standard of identity or
appropriate common or usual name, the
product must be identified by a
descriptive name (9 CFR 317.2(e) and
381.117(a)).
Words or statements that are required
to appear on product labeling must be
in terms likely to be understood by the
ordinary individual under customary
conditions of purchase and use (21
U.S.C. 601(n)(6) and 453(h)(6)). In some
instances, FSIS may require qualifying
language to appear on product labels
when necessary to ensure product
names are not misleading. For example,
a product identified as a ‘‘turkey-ham,’’
must be qualified with the statement
‘‘cured turkey thigh meat’’ (9 CFR
381.171).
C. FSIS Evaluation of Product Labels
To prevent misbranded products from
entering commerce, the Acts require
FSIS to approve meat and poultry
product labels before they may be used
in commerce (21 U.S.C. 607(d) and
457(c)). To that end, FSIS implements a
prior approval program for labels used
on meat and poultry products (9 CFR
part 412). Under the program, labels that
bear only mandatory labeling features 2,
otherwise comply with the Agency’s
labeling regulations, and bear only
claims that are defined in the
regulations or are factual statements not
considered a special statement or claim,
are deemed ‘‘generically approved’’ and,
thus, not subject to FSIS review before
entering commerce. These labels are,
however, subject to periodic compliance
verification by FSIS inspectors in the
field (FSIS Directive 7221.1, Prior
Labeling Approval).
FSIS must review and approve all
other labels before they are used on
products intended for distribution in
2 There are up to eight mandatory label features
for each product label: (1) Product name, (2)
inspection legend and establishment number, (3)
handling statement, (4) net weight statement, (5)
ingredients statement, (6) address line, (7) nutrition
facts, and (8) safe handling instructions.
E:\FR\FM\03SEP1.SGM
03SEP1
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
commerce. This includes labels that
display special statements or claims.3
Special statements or claims include
those not defined by regulation or
policy, organic claims, health claims,
ingredient and processing method
claims, structure-function claims,
animal-raising claims, and instructional
or disclaimer statements concerning
pathogens (9 CFR 412.1(e)).4
Establishments must provide FSIS with
documentation and data to support
special statements and claims for
Agency review, or the labels will not be
approved.
The labels for cell cultured products
under FSIS jurisdiction will be subject
to premarket review under the same
process as other special statements or
claims. This will ensure that labeling for
products developed using cell culture
technology are not false or misleading,
that labeling requirements are applied
consistently as these novel products
enter the marketplace, and that the label
provides the necessary product
information for consumers to make
informed purchasing decisions. FSIS
has provided for generic approval of
labeling features, statements, and claims
based on demonstrated prevalent
industry understanding of the effective
application of those features,
statements, or claims and consumer
understanding of labeling statements.
No widespread industry understanding
of the labeling requirements for cell
cultured meat and poultry products
currently exists. Similarly, consumers
have not yet had experience reading
these types of labels.
B. Evaluating the Need for New Labeling
Requirements
FSIS has established numerous
labeling requirements for meat and
poultry products in response to, among
other things, the advent of new methods
of production. In assessing the labeling
of meat and poultry products developed
using new methods or technologies, the
Agency typically focuses on the
biological, chemical, nutritional, and
organoleptic characteristics of the
finished product. The statutory and
regulatory definitions of meat and
poultry are also pertinent.
Pursuant to 9 CFR 301.2, the term
‘‘meat’’ refers to the muscle of amenable
lotter on DSK11XQN23PROD with PROPOSALS1
3 Other
types of labels that require prior review
include labels for religious exempt products, labels
for export with deviations from domestic labeling
requirements, and labels for temporary approval (9
CFR 412.1(c)).
4 On September 14, 2020, FSIS published the
Prior Label Approval System: Expansion of Generic
Label Approval proposed rule, which proposes
amendments to the generic labeling and special
statements and claims provisions of 9 CFR part 412.
(85 FR 56538).
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
livestock that is skeletal or found in the
tongue, diaphragm, heart, or esophagus,
with or without the bone, skin, sinew,
nerve, and blood vessels, which
normally accompany such tissue and
are not separated from it in the process
of dressing. Meat does not include the
muscle found in the lips, snout, or ears,
or significant portions of bone or related
components, or any amount of brain,
trigeminal ganglia, spinal cord, or dorsal
root ganglia.5 Any part of amenable
livestock that is capable of use as
human food, but does not qualify as
‘‘meat,’’ is a ‘‘meat byproduct.’’ Any
article capable of use as human food
that is made wholly or in part from any
meat or other portion of amenable
livestock is a ‘‘meat food product’’ (21
U.S.C. 601(j)).
Regarding poultry, the PPIA and its
implementing regulations define the
term ‘‘poultry product’’ as any poultry
carcass or part thereof; or any product
which is made wholly or in part from
any poultry carcass or part thereof (21
U.S.C. 453(f); 9 CFR 381.1). The term
‘‘poultry food product’’ refers to any
product capable of use as human food
which is made in part from any poultry
carcass or part thereof (9 CFR 381.1).
If a new method of production or
processing alters the biological,
chemical, nutritional, or organoleptic
properties of meat or poultry to the
extent that the resulting product no
longer aligns with consumers’
expectations, FSIS establishes new label
requirements to ensure consumers’
expectations are met. For example, in
1995, FSIS evaluated the need to
establish new labeling requirements for
mechanically separated poultry (MSP)
(60 FR 55962, November 3, 1995). FSIS
found that this novel method of deriving
poultry products using the mechanical
separation process resulted in a product
whose physical form, texture, and
ingredients, e.g., bone content, differ
materially from those of other boneless
poultry products produced by hand
deboning techniques. FSIS therefore
established a new standard of identity
for MSP (9 CFR 381.173) to ensure
consumer expectations are met.
Conversely, in 2004, FSIS evaluated
the need to establish new labeling
requirements for meat derived using
advanced meat recovery (AMR) systems
5 Specified
risk materials (SRMs) are inedible and
must be removed from all cattle presented for
slaughter in accordance with 9 CFR 310.22. SRMs
include the brain, skull, eyes, trigeminal ganglia,
spinal cord, vertebral column (excluding the
vertebrae of the tail, the transverse processes of the
thoracic and lumbar vertebrae, and the wings of the
sacrum), and dorsal root ganglia from cattle 30
months of age and older (9 CFR 310.22(a)(1)). SRMs
also include the distal ileum of the small intestine
and the tonsils from all cattle (9 CFR 310.22(a)(2)).
PO 00000
Frm 00004
Fmt 4702
Sfmt 4702
49493
(69 FR 1874, January 12, 2004). There,
FSIS found that AMR product was
comparable to meat derived by hand
deboning in terms of its composition,
appearance, and texture so long as it
was produced in accordance with the
regulations. FSIS therefore did not need
to establish new labeling regulations for
AMR products to meet consumer
expectations. Instead, the Agency set
compositional criteria for AMR products
and modified the definition of ‘‘meat’’ to
make it clear that boneless meat
products, such as AMR products, may
not include a significant portion of bone
or related components (9 CFR 318.24).
C. FDA–FSIS Joint Agreement Regarding
Oversight of Human Food Produced
Using Animal Cell Technology Derived
From Cell Lines of USDA-Amenable
Species
On March 7, 2019, the Food and Drug
Administration (FDA) and FSIS signed
a formal agreement to jointly oversee the
production of human food products
comprised of or containing cultured
cells derived from cell lines of those
species covered under the Acts.6 The
agreement describes each agency’s
intended role with respect to the
oversight of such products. In summary,
FDA will oversee the collection, growth
and differentiation of livestock and
poultry cells until cell harvest. A
transition from FDA to FSIS oversight
will occur during the cell harvest stage.
FSIS will then oversee the processing,
packaging, and labeling of the resulting
meat and poultry products made using
animal cell culture technology.
FDA will continue to have the sole
responsibility to regulate foods for
animals, as well as for those foods for
humans comprised of or containing
cultured animal cells from species
under FDA’s jurisdiction, i.e., those not
amenable to the FMIA or PPIA, such as
seafood species other than Siluriformes
fish.7 In the formal agreement, FSIS and
FDA have agreed to develop joint
principles for product labeling and
claims to ensure that FDA and FSIS
regulated products are labeled
consistently and transparently and work
developing those principles is
continuing. On October 7, 2020, FDA
published a Request for Information
6 Formal agreement between the U.S. Department
of Health and Human Services Food and Drug
Administration and U.S. Department of Agriculture
Office of Food Safety Regarding Oversight of
Human Food Produced Using Animal Cell
Technology Derived from Cell Lines of USDAamenable Species, March 7, 2019, available at
https://www.fsis.usda.gov/sites/default/files/media_
file/2020-07/Formal-Agreement-FSIS-FDA.pdf.
7 FDA also has jurisdiction over products with
3% or less raw meat or less than 2% cooked meat
or poultry meat.
E:\FR\FM\03SEP1.SGM
03SEP1
49494
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
lotter on DSK11XQN23PROD with PROPOSALS1
(RFI), similar to this ANPR, soliciting
comments on the labeling of seafood
products under their jurisdiction and
made using animal cell culture
technology (Labeling of Foods
Comprised of or Containing Cultured
Seafood Cells; Request for Information;
85 FR 63277). FSIS will consider
comments submitted in response to
FDA’s RFI as it develops rules governing
the labeling of cell cultured products, to
the extent they are relevant to the
development of joint labeling principles
and the regulation of meat and poultry.
D. United States Cattlemen’s
Association Petition
The United States Cattlemen’s
Association (USCA) filed a petition
dated February 9, 2018, with FSIS
regarding the labeling of cultured meat.8
The petition requests that FSIS limit the
definition of ‘‘beef’’ to products derived
from cattle born, raised, and harvested
in the traditional manner, and thereby
prohibit foods comprised of or
containing cultured animal cells from
being labeled as ‘‘beef.’’ The petition
similarly requests that FSIS limit the
definition of ‘‘meat’’ to the tissue or
flesh of animals that have been
harvested in the traditional manner, and
thereby prohibit foods comprised of or
containing cultured animal cells from
being labeled as ‘‘meat.’’
FSIS received over 6000 comments 9
on the petition from trade associations,
consumer advocacy groups, businesses
operating in the meat, poultry, and
cultured food product markets, and
consumers. Most comments opposed the
petition overall; however, nearly all
generally agreed that cultured meat and
beef should be labeled in a manner that
indicates how it was produced and
differentiates it from slaughtered meat
products.
Several commenters, both for and
against the petition, discussed the
nature and source of cultured meat to
support their arguments. Generally,
commenters in support of the petition
argued that cultured meat will not have
the same characteristics as slaughtered
meat or beef and, thus, should not be
marketed as such. Commenters opposed
to the petition, however, noted that
cultured meat is derived from the same
species as slaughtered meat and beef
and can be produced with substantially
similar characteristics as such products.
8 Petition 18–01 Submitted by the U.S.
Cattlemen’s Association, February 9, 2018, available
at https://www.fsis.usda.gov/federal-register/
petitions/petition-limit-definition-beef-traditionalsources.
9 Public comments on Petition 18–01 are available
at https://www.regulations.gov/document/FSIS2018-0016-0001/comment.
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
Many commenters opposed to the
petition also argued that the terms
‘‘meat’’ and ‘‘beef’’ were necessary to
inform consumers of the texture, shape,
and function of certain cultured meat
products.
Commenters in support of the petition
typically favored the creation of a
standard of identity to differentiate
slaughtered meat and beef from cultured
products. Some livestock industry
organizations that opposed the petition
overall, also supported the creation of a
standard of identity for cultured meat
products. However, most opposed to the
petition argued that standards of
identity are not warranted, based on
their assertions that cultured products,
like slaughtered products, fall within
the statutory and regulatory definitions
of ‘‘meat’’ or ‘‘meat food product’’ under
the FMIA.
Finally, some commenters expressed
concern that the petition, if granted,
would hamper innovation and, thereby,
hurt the meat industry. A few others
opposed the petition contending that
the regulation of cultured meat labeling
would violate the First Amendment.
E. Public Meeting on Animal Cell
Culture Technology
FSIS and FDA held a joint public
meeting in October 2018 to discuss the
potential hazards, oversight
considerations, and labeling of cultured
food products derived from livestock
and poultry tissue (83 FR 46476). The
aforementioned USCA petition was also
a topic of discussion. Transcripts of the
meeting are available on the FSIS
website.10
FSIS received approximately 315
comments on the joint public meeting,
many of which were concerned with the
labeling of cultured meat and poultry
products. Comments expressed
divergent views on whether cultured
meat products should be labeled
‘‘meat.’’ Many felt the term would be
misleading, arguing that cultured
products are not produced in the same
manner as, nor share substantially
similar characteristics with, traditional
meat. Some, however, felt it would be
misleading not to refer to cultured
products as ‘‘meat,’’ arguing that such
products are derived from the same
amenable livestock and can be produced
to have the same characteristics as
slaughtered meat products.
Many on both sides of the issue
agreed that the product name and other
10 USDA and FDA Joint Public Meeting on the
Use of Cell Culture Technology to Develop Products
Derived from Livestock and Poultry, October 23–24,
2018, available at https://www.fsis.usda.gov/newsevents/events-meetings/usda-and-fda-joint-publicmeeting-use-cell-culture-technology-develop.
PO 00000
Frm 00005
Fmt 4702
Sfmt 4702
information on cultured meat and
poultry product labels should indicate
they were made using animal cell
culture technology. Some also asked
FSIS to establish standards of identity
for cultured products. A few
commenters, however, opposed such
requirements, reasoning that animal cell
culture technology does not alter the
basic characteristics of the foods and
that a standard of identity or other new
labeling rules would stifle innovation in
the cultured foods industry. A few
comments were also concerned that new
labeling requirements would
unnecessarily put cultured products at a
competitive disadvantage to slaughtered
products.
Commenters were also concerned
with the regulation of special statements
and claims on cell cultured products
labels. Many comments asked FSIS to
subject such claims to the same prior
label approval process and oversight as
slaughtered products. Others asked FSIS
to establish specific guidance for such
claims to ensure they are truthful and
supported by sound science. A few
advocated that animal cell culture
technology companies be allowed to
make special statements and claims
about the environmental, food safety,
and other benefits of their products, so
long as they provide evidence to
support such assertions.
F. Harvard Law School Animal Law &
Policy Clinic Petition
FSIS also has received a petition from
the Harvard Law School Animal Law &
Policy Clinic dated June 9, 2020,
concerning the labeling of products
made using animal cell culture
technology.11 The petition requests that
FSIS adopt a labeling approach for
cultured meat and poultry products that
respects First Amendment commercial
speech protections. The petition
specifically requests that FSIS establish
a labeling approach that does not
require new standards of identity and
does not ban the use of common or
usual meat or poultry terms or other
product terms specified in regulatory
standards of identity. The petition
asserts that FSIS should wait until the
Agency has a better understanding of
the compositional and safety
characteristics of finished products
made using animal cell culture
technology, and until it has had the
opportunity to review proposed labels,
before establishing speech restrictions
that could raise constitutional
11 Petition 20–03 Submitted by Harvard Law
School Animal Law & Policy Clinic, June 9, 2020,
available at https://www.fsis.usda.gov/policy/
petitions/.
E:\FR\FM\03SEP1.SGM
03SEP1
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
questions. To date, FSIS received one
comment from a non-profit
organization, conveying broad support
for the petition.
G. U.S. Government Accountability
Office Report
The U.S. Government Accountability
Office (GAO) recently completed a
review to, in part, understand how
much information on the commercial
production of cultured meat and poultry
is available to federal regulators,
including FSIS.12 It found that federal
regulators lack specific information on
the technology being used, eventual
commercial production methods, and
composition of the final products. FSIS
hopes to receive such information in
response to this ANPR, so that it can
make informed decisions regarding the
labeling of these products.
lotter on DSK11XQN23PROD with PROPOSALS1
II. Issues for Comment
FSIS invites comment on the issues
discussed in this ANPR to help inform
future rulemaking on the labeling of
products made using animal cell-culture
technology. Specifically, FSIS seeks
responses to the questions listed below.
Please explain the reasoning behind
your responses in detail. Also, provide
any data, studies, or other evidence that
supports your response. To help FSIS
review comments efficiently, please
identify the question to which you are
responding by its associated number
and letter (e.g., ‘‘2a’’) or whether you are
commenting on a topic not listed below.
1. Should the product name of a meat or
poultry product comprised of or containing
cultured animal cells differentiate the
product from slaughtered meat or poultry by
informing consumers the product was made
using animal cell culture technology? If yes,
what criteria should the agency consider or
use to differentiate the products? If no, why
not?
2. What term(s), if any, should be in the
product name of a food comprised of or
containing cultured animal cells to convey
the nature or source of the food to
consumers? (e.g., ‘‘cell cultured’’ or ‘‘cell
cultivated.’’)
a. How do these terms inform consumers
of the nature or source of the product?
b. What are the benefits or costs to industry
and consumers associated with these terms?
c. If meat or poultry products comprised of
or containing cultured animal cells were to
be labeled with the term ‘‘culture’’ or
‘‘cultured’’ in their product names or
standards of identity (e.g., ‘‘cell culture[d]’’),
would labeling differentiation be necessary to
distinguish these products from other types
of foods where the term ‘‘culture’’ or
12 U.S. Government Accountability Office, Food
Safety: FDA and USDA Could Strengthen Existing
Efforts to Prepare for Oversight of Cell-Cultured
Meat, April 2020, available at: https://www.gao.gov/
products/gao-20-325.
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
‘‘cultured’’ is used (such as ‘‘cultured celery
powder’’)?
3. If a meat or poultry product were
comprised of both slaughtered meat or
poultry and cultured animal cells, what
unique labeling requirements, if any, should
be required for such products?
4. What term(s), if used in the product
name of a food comprised of or containing
cultured animal cells, would be potentially
false or misleading to consumers? For each
term, please provide your reasoning.
5. What term(s), if used in the product
name of a food comprised of or containing
cultured animal cells, would potentially have
a negative impact on industry or consumers?
For each term, please provide your reasoning.
6. Should names for slaughtered meat and
poultry products established by common
usage (e.g., Pork Loin), statute, or regulation
be included in the names or standards of
identity of such products derived from
cultured animal cells?
a. If so, is additional qualifying language
necessary? What qualifying terms or phrases
would be appropriate?
b. Do these names, with or without
qualifying language, clearly distinguish foods
comprised of or containing cultured animal
cells from slaughtered products?
7. Should terms that specify the form of
meat or poultry products (such as ‘‘fillet’’,
‘‘patty’’, or ‘‘steak’’) be allowed to be
included in or to accompany the name or
standard of identity of foods comprised of or
containing cultured animal cells?
a. Under what circumstances should these
terms be used?
b. What information would these terms
convey to consumers?
8. Should FSIS establish a regulatory
standard of identity under its authorities in
the FMIA and the PPIA (21 U.S.C. 607(c) and
457(b)) for foods comprised of or containing
cultured animal cells?
a. If so, what would be the standard and
how might compliance with the standard be
verified?
b. If so, what would be the labeling
terminology for products that do and do not
meet a formal standard of identity? What
would be the anticipated categories of use?
For example, mechanically separated poultry
that does not meet the standards of identity
outlined in 9 CFR 381.173 may be diverted
for production in broths and bases, as well
as reaction flavors, i.e., flavors produced by
the heating of the protein source in the
presence of a reducing sugar.
c. If so, what are the benefits and costs to
industry if the standard of identity is
established? Please provide quantitative and
qualitative feedback in your response and
explain the basis of any quantitative
estimates.
d. If so, what are the consumer benefits and
costs to the standard of identity
recommended?
9. What nutritional, organoleptic (e.g.,
appearance, odor, taste), biological, chemical,
or other characteristics, material to
consumers’ purchasing and consumption
decisions, vary between slaughtered meat or
poultry products and those comprised of or
containing cultured animal cells?
10. Should any of the definitions for
‘‘meat’’, ‘‘meat byproduct’’, or ‘‘meat food
PO 00000
Frm 00006
Fmt 4702
Sfmt 4702
49495
product’’ found in 9 CFR 301.2 be amended
to specifically include or exclude foods
comprised of or containing cultured animal
cells?
11. Should any of the definitions for
‘‘poultry product’’ or ‘‘poultry food product’’
found in 9 CFR 381.1 be amended to
specifically include or exclude foods
comprised of or containing cultured animal
cells?
12. Should FSIS-regulated broths, bases,
and reaction flavors produced from cultured
animal cells be required to declare the source
material in the product name, ingredient sublisting, or elsewhere on the label?
13. Should the presence of cultured animal
cells in further processed products regulated
by FSIS, such as a lasagna made with cell
cultured beef cells as an ingredient, be
qualified on the product label? If so, how
should this be qualified?
14. What label claims are likely to appear
on FSIS-regulated products comprised of or
containing cultured animal cells? Should
FSIS develop new regulations or guidance on
such claims to ensure they are neither false
nor misleading?
III. Request for Economic Data and
Consumer Research
Along with the above questions about
the costs and benefits of labeling
options for cell cultured meat and
poultry, FSIS seeks economic data and
consumer research to help increase its
understanding of the animal cell culture
technology industry and related issues
regarding labeling and consumer
perceptions of food made using this
technology. FSIS is particularly
interested in information regarding: (1)
The impact of the labeling of cell
cultured meat and poultry on
consumers’ perception of and
willingness to pay for cultured meat and
poultry products; (2) the expected price
per pound of cultured meat and poultry
products; (for example, FSIS has
reviewed recent studies that discuss
consumer perception 13 and willingness
to pay 14 for cultured meat products); (2)
the expected price per pound of
cultured meat and poultry products; (3)
the number of domestic and the number
of international animal cell culture
technology companies estimated to
enter the U.S. market (for example, FSIS
is aware of eight domestic companies
who belong to the Alliance for Meat,
Poultry and Seafood Innovation (AMPS
13 Kantor, Bella Nichole, Kantor, Jonathan. Public
Attitudes and Willingness to Pay for Cultured Meat:
A Cross-Sectional Experimental Study. Frontiers in
Sustainable Food Systems. Volume 5 (2021) pg 26.
Accessed on June 22, 2021: https://
www.frontiersin.org/articles/10.3389/
fsufs.2021.594650/full.
14 Rolland NCM, Markus CR, Post MJ. The Effect
of Information Content on Acceptance of Cultured
Meat in a Tasting Context. PLOS ONE 15(4):
e0231176(2020) Accessed on June 22, 2021: https://
journals.plos.org/plosone/article?id=10.1371/
journal.pone.0231176.
E:\FR\FM\03SEP1.SGM
03SEP1
49496
Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Proposed Rules
Innovation) trade association); (4) the
expected average annual volume per
company, broken down by species or
product type; (5) the expected number
of labels per company, broken down by
species or product type; (6) company
size by expected revenue and number of
employees; (7) data on the consumer
benefits from labels that clearly identify
or differentiate cultured meat and
poultry products (e.g., saved research
costs); and (8) information on naming
conventions that would discourage
consumer purchases or producer
innovations and the associated
economic impact. FSIS also seeks
consumer research related to labeling
nomenclature for products made using
animal cell culture technology.
lotter on DSK11XQN23PROD with PROPOSALS1
IV. Label Evaluation Prior to
Rulemaking
Should any establishment wish to
distribute a cultured meat or poultry
product in commerce prior to related
labeling rulemaking being completed,
the establishment would need to submit
the product label to FSIS for review. To
learn about the process for submitting
labels to FSIS, please see the ‘‘Labeling
and Label Approval’’ web page.15 As
discussed above, labels for cultured
product are not eligible for generic
approval at this time because neither
industry nor consumers have experience
with cultured products or their labels.
Therefore, FSIS will need to review and
approve cultured meat and poultry
product labels before they are used in
commerce to ensure they are not false or
misleading. During label review, FSIS
will ensure the labels clearly
differentiate cell cultured product from
slaughtered meat and poultry products
and will ensure the labels bear all
mandatory features required by the
regulations for meat and poultry
products. Labels approved for cell
cultured meat and poultry products
prior to the conclusion of this
rulemaking may need to be changed for
compliance with the requirements of
final regulations.
V. USDA Non-Discrimination Statement
In accordance with Federal civil
rights law and U.S. Department of
Agriculture (USDA) civil rights
regulations and policies, the USDA, its
Agencies, offices, and employees, and
institutions participating in or
administering USDA programs are
prohibited from discriminating based on
race, color, national origin, religion, sex,
gender identity (including gender
15 FSIS Labeling and Label Approval web page,
https://www.fsis.usda.gov/inspection/complianceguidance/labeling.
VerDate Sep<11>2014
16:19 Sep 02, 2021
Jkt 253001
expression), sexual orientation,
disability, age, marital status, family/
parental status, income derived from a
public assistance program, political
beliefs, or reprisal or retaliation for prior
civil rights activity, in any program or
activity conducted or funded by USDA
(not all bases apply to all programs).
Remedies and complaint filing
deadlines vary by program or incident.
Persons with disabilities who require
alternative means of communication for
program information (e.g., Braille, large
print, audiotape, American Sign
Language, etc.) should contact the
responsible Agency or USDA’s TARGET
Center at (202) 720–2600 (voice and
TTY) or contact USDA through the
Federal Relay Service at (800) 877–8339.
Additionally, program information may
be made available in languages other
than English.
To file a program discrimination
complaint, complete the USDA Program
Discrimination Complaint Form, AD–
3027, found online at https://
www.usda.gov/oascr/how-to-file-aprogram-discrimination-complaint and
at any USDA office or write a letter
addressed to USDA and provide in the
letter all of the information requested in
the form. To request a copy of the
complaint form, call (866) 632–9992.
Submit your completed form or letter to
USDA by: (1) Mail: U.S. Department of
Agriculture, Office of the Assistant
Secretary for Civil Rights, 1400
Independence Avenue SW, Washington,
DC 20250–9410; (2) fax: (202) 690–7442;
or (3) email: program.intake@usda.gov.
USDA is an equal opportunity
provider, employer, and lender.
VI. Additional Public Notification
Public awareness of all segments of
rulemaking and policy development is
important. Consequently, FSIS will
announce this Federal Register
publication online through the FSIS
web page located at: https://
www.fsis.usda.gov/federal-register.
FSIS also will announce and provide
a link to it through the FSIS Constituent
Update, which is used to provide
information regarding FSIS policies,
procedures, regulations, Federal
Register notices, FSIS public meetings,
and other types of information that
could affect or would be of interest to
our constituents and stakeholders. The
Constituent Update is available on the
FSIS web page. Through the web page,
FSIS is able to provide information to a
much broader, more diverse audience.
In addition, FSIS offers an email
subscription service which provides
automatic and customized access to
selected food safety news and
information. This service is available at
PO 00000
Frm 00007
Fmt 4702
Sfmt 4702
https://www.fsis.usda.gov/subscribe.
Options range from recalls to export
information, regulations, directives, and
notices. Customers can add or delete
subscriptions themselves and have the
option to password protect their
accounts.
Paul Kiecker,
Administrator.
[FR Doc. 2021–19057 Filed 9–2–21; 8:45 am]
BILLING CODE 3410–DM–P
FARM CREDIT ADMINISTRATION
12 CFR Part 615
RIN 3052–AD44
Bank Liquidity Reserve
Farm Credit Administration.
Advance notice of proposed
rulemaking; extension of comment
period.
AGENCY:
ACTION:
The Farm Credit
Administration (FCA or we) is
extending the comment period on its
Advance Notice of Proposed
Rulemaking (ANPRM) that seeks
comment from the public about whether
and how FCA should revise its liquidity
regulatory framework for Farm Credit
System (System) banks. FCA is
extending the comment period for an
additional 60 days, until November 27,
2021, so interested parties will have
additional time to provide comments on
the ANPRM.
DATES: The comment period for the
Advance Notice of Proposed
Rulemaking on Bank Liquidity Reserves,
published on June 30, 2021 (86 FR
34645), is extended from September 28,
2021, to November 27, 2021.
ADDRESSES: For accuracy and efficiency
reasons, please submit comments by
email or through FCA’s website. We do
not accept comments submitted by
facsimiles (fax), as faxes are difficult for
us to process and achieve compliance
with section 508 of the Rehabilitation
Act of 1973. Please do not submit your
comment multiple times via different
methods. You may submit comments by
any of the following methods:
• Email: Send us an email at regcomm@fca.gov.
• FCA website: https://www.fca.gov.
Click inside the ‘‘I want to . . .’’ field
near the top of the page; select
‘‘comment on a pending regulation’’
from the dropdown menu; and click
‘‘Go.’’ This takes you to an electronic
public comment form.
• Mail: Kevin J. Kramp, Director,
Office of Regulatory Policy, Farm Credit
SUMMARY:
E:\FR\FM\03SEP1.SGM
03SEP1
Agencies
[Federal Register Volume 86, Number 169 (Friday, September 3, 2021)]
[Proposed Rules]
[Pages 49491-49496]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19057]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF AGRICULTURE
Food Safety and Inspection Service
9 CFR Chapter III
[Docket No. FSIS-2020-0036]
RIN 0583-AD89
Labeling of Meat or Poultry Products Comprised of or Containing
Cultured Animal Cells
AGENCY: Food Safety and Inspection Service, USDA.
ACTION: Advance notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Food Safety and Inspection Service (FSIS) is publishing
this advance notice of proposed rulemaking (ANPR) to request comments
pertaining to the labeling of meat and poultry products comprised of or
containing cultured cells derived from animals subject to the Federal
Meat Inspection Act or the Poultry Products Inspection Act. Issues
raised in the comments submitted in response to this ANPR will inform
future rulemaking to establish labeling requirements for these
products. This ANPR also discusses how FSIS will generally evaluate
labels for these products if they are submitted before the Agency
completes rulemaking.
DATES: Submit comments on or before November 2, 2021.
ADDRESSES: FSIS invites interested persons to submit comments on this
document. Comments may be submitted by one of the following methods:
Federal eRulemaking Portal: This website provides the
ability to type short comments directly into the comment field on this
web page or attach a file for lengthier comments. Go to https://www.regulations.gov. Follow the on-line instructions at that site for
submitting comments.
Mail: Send to Docket Clerk, U.S. Department of
Agriculture, Food Safety and Inspection Service, 1400 Independence
Avenue SW, Mailstop 3758, Washington, DC 20250-3700.
Hand- or courier-delivered submittals: Deliver to 1400
Independence Avenue SW, Jamie L. Whitten Building, Room 350-E,
Washington, DC 20250-3700.
[[Page 49492]]
Instructions: All items submitted by mail or electronic mail must
include the Agency name and docket number FSIS-2020-0036. Comments
received in response to this docket will be made available for public
inspection and posted without change, including any personal
information, to https://www.regulations.gov.
Docket: For access to background documents or comments received,
call (202) 720-5627 to schedule a time to visit the FSIS Docket Room at
1400 Independence Avenue SW, Washington, DC 20250-3700.
FOR FURTHER INFORMATION CONTACT: Rachel Edelstein, Assistant
Administrator, Office of Policy and Program Development by telephone at
(202) 205-0495.
SUPPLEMENTARY INFORMATION:
I. Background
This ANPR concerns the labeling of meat and poultry products
produced using animal cell culture technology, including how these
products are to be identified and described specifically in regard to
their nature, source, or characteristics. Animal cell culture
technology is a process that involves taking a small number of cells
from living animals and growing them in a controlled environment to
create food, among other things. Scientists typically start with a
sample of cells from the tissue of an animal, some of which are
selected, screened, and stored for future use. Later, some of these
stored cells are retrieved and placed in a controlled environment with
appropriate nutrients and other factors to support growth and cellular
multiplication. After the cells have multiplied, additional inputs such
as growth factors, new surfaces for cell attachment, and additional
nutrients are added to the controlled environment to enable the cells
to differentiate into various cell types. Once produced, the harvested
cells can be processed, packaged, and marketed in the same, or similar,
manner as slaughtered \1\ meat and poultry products. This ANPR refers
to such foods as ``cultured'' meat and poultry products or as products
compromised of or containing ``cultured'' animal cells. The use of this
term, however, is not intended to establish or suggest nomenclature for
labeling purposes.
---------------------------------------------------------------------------
\1\ This ANPR refers to all meat or poultry products not
produced using animal cell culture technology as ``slaughtered''
meat and poultry products.
---------------------------------------------------------------------------
Many companies, both domestic and foreign, are currently developing
cultured products derived from the cells of food animals amenable to
the Federal Meat Inspection Act (FMIA; 21 U.S.C. 601 et. seq.) (cattle,
sheep, swine, goats, and fish of the order Siluriformes, e.g., catfish)
or the Poultry Products Inspection Act (PPIA; 21 U.S.C. 451 et seq.)
(chickens, turkeys, ducks, geese, guineas, ratites, and squabs). Human
food products derived from these species (hereinafter ``meat and
poultry products'') fall under FSIS jurisdiction. Under the FMIA and
PPIA (hereinafter ``the Acts''), FSIS regulates the labeling of all
meat and poultry products under its jurisdiction to ensure such
products are not misbranded (21 U.S.C. 607(d) and 457(c)). FSIS is now
seeking comments to inform future regulatory requirements for the
labeling of cultured meat and poultry products intended to prevent
misbranding.
A. FSIS Authority Over the Labeling of Cultured Meat and Poultry
Products
FSIS is the federal agency that, under the authority of the Acts,
protects public health by ensuring that meat and poultry products are
wholesome, not adulterated, and properly marked, labeled, and packaged.
To that end, FSIS issues and enforces federal regulations to ensure,
among other things, that meat and poultry products in commerce within
the United States are not misbranded (21 U.S.C. 607(d) and 457(c)).
With limited exceptions, U.S. states or territories may not impose
requirements within the scope of the Acts--such as labeling
requirements--that are in addition to, or different from, the
requirements established by the Acts or their implementing regulations
(21 U.S.C. 678 and 476e).
B. Relevant Misbranding Provisions Under the Acts
Under the Acts, a meat or poultry product is misbranded under a
number of circumstances. In general, it is misbranded if its labeling
is false or misleading in any particular (21 U.S.C. 601(n)(1) and
453(h)(1)). It is also misbranded if it is offered for sale under the
name of another food (21 U.S.C. 601(n)(2) and 453(h)(2)) or if it is an
imitation of another food, but not labeled as such (21 U.S.C. 601(n)(3)
and 453 (h)(3)).
A product is also misbranded if it purports to be or is represented
as a food for which a standard of identity has been prescribed, without
conforming to the standard (21 U.S.C. 601(n)(7) and 453(h)(7)). FSIS
has authority to establish standards of identity for meat and poultry
products to help ensure such products have the characteristics expected
by consumers (21 U.S.C. 607(c) and 457(b)). Standards of identity
establish specific names, terms, and information to be used on product
labels. Standards may also require the presence of certain expected
ingredients in products, regulate the minimum or maximum amount of
ingredients in products, or specify how products are formulated,
processed, or prepared.
If a product is not covered by a standard of identity, it is
misbranded unless its label bears the common or usual name of the food,
if there is one, and the common or usual name of its ingredients (21
U.S.C. 601(n)(9) and 453(h)(9)). Common or usual names are generally
established by common usage but, in some cases, they may be established
by regulation. In the absence of either a standard of identity or
appropriate common or usual name, the product must be identified by a
descriptive name (9 CFR 317.2(e) and 381.117(a)).
Words or statements that are required to appear on product labeling
must be in terms likely to be understood by the ordinary individual
under customary conditions of purchase and use (21 U.S.C. 601(n)(6) and
453(h)(6)). In some instances, FSIS may require qualifying language to
appear on product labels when necessary to ensure product names are not
misleading. For example, a product identified as a ``turkey-ham,'' must
be qualified with the statement ``cured turkey thigh meat'' (9 CFR
381.171).
C. FSIS Evaluation of Product Labels
To prevent misbranded products from entering commerce, the Acts
require FSIS to approve meat and poultry product labels before they may
be used in commerce (21 U.S.C. 607(d) and 457(c)). To that end, FSIS
implements a prior approval program for labels used on meat and poultry
products (9 CFR part 412). Under the program, labels that bear only
mandatory labeling features \2\, otherwise comply with the Agency's
labeling regulations, and bear only claims that are defined in the
regulations or are factual statements not considered a special
statement or claim, are deemed ``generically approved'' and, thus, not
subject to FSIS review before entering commerce. These labels are,
however, subject to periodic compliance verification by FSIS inspectors
in the field (FSIS Directive 7221.1, Prior Labeling Approval).
---------------------------------------------------------------------------
\2\ There are up to eight mandatory label features for each
product label: (1) Product name, (2) inspection legend and
establishment number, (3) handling statement, (4) net weight
statement, (5) ingredients statement, (6) address line, (7)
nutrition facts, and (8) safe handling instructions.
---------------------------------------------------------------------------
FSIS must review and approve all other labels before they are used
on products intended for distribution in
[[Page 49493]]
commerce. This includes labels that display special statements or
claims.\3\ Special statements or claims include those not defined by
regulation or policy, organic claims, health claims, ingredient and
processing method claims, structure-function claims, animal-raising
claims, and instructional or disclaimer statements concerning pathogens
(9 CFR 412.1(e)).\4\ Establishments must provide FSIS with
documentation and data to support special statements and claims for
Agency review, or the labels will not be approved.
---------------------------------------------------------------------------
\3\ Other types of labels that require prior review include
labels for religious exempt products, labels for export with
deviations from domestic labeling requirements, and labels for
temporary approval (9 CFR 412.1(c)).
\4\ On September 14, 2020, FSIS published the Prior Label
Approval System: Expansion of Generic Label Approval proposed rule,
which proposes amendments to the generic labeling and special
statements and claims provisions of 9 CFR part 412. (85 FR 56538).
---------------------------------------------------------------------------
The labels for cell cultured products under FSIS jurisdiction will
be subject to premarket review under the same process as other special
statements or claims. This will ensure that labeling for products
developed using cell culture technology are not false or misleading,
that labeling requirements are applied consistently as these novel
products enter the marketplace, and that the label provides the
necessary product information for consumers to make informed purchasing
decisions. FSIS has provided for generic approval of labeling features,
statements, and claims based on demonstrated prevalent industry
understanding of the effective application of those features,
statements, or claims and consumer understanding of labeling
statements. No widespread industry understanding of the labeling
requirements for cell cultured meat and poultry products currently
exists. Similarly, consumers have not yet had experience reading these
types of labels.
B. Evaluating the Need for New Labeling Requirements
FSIS has established numerous labeling requirements for meat and
poultry products in response to, among other things, the advent of new
methods of production. In assessing the labeling of meat and poultry
products developed using new methods or technologies, the Agency
typically focuses on the biological, chemical, nutritional, and
organoleptic characteristics of the finished product. The statutory and
regulatory definitions of meat and poultry are also pertinent.
Pursuant to 9 CFR 301.2, the term ``meat'' refers to the muscle of
amenable livestock that is skeletal or found in the tongue, diaphragm,
heart, or esophagus, with or without the bone, skin, sinew, nerve, and
blood vessels, which normally accompany such tissue and are not
separated from it in the process of dressing. Meat does not include the
muscle found in the lips, snout, or ears, or significant portions of
bone or related components, or any amount of brain, trigeminal ganglia,
spinal cord, or dorsal root ganglia.\5\ Any part of amenable livestock
that is capable of use as human food, but does not qualify as ``meat,''
is a ``meat byproduct.'' Any article capable of use as human food that
is made wholly or in part from any meat or other portion of amenable
livestock is a ``meat food product'' (21 U.S.C. 601(j)).
---------------------------------------------------------------------------
\5\ Specified risk materials (SRMs) are inedible and must be
removed from all cattle presented for slaughter in accordance with 9
CFR 310.22. SRMs include the brain, skull, eyes, trigeminal ganglia,
spinal cord, vertebral column (excluding the vertebrae of the tail,
the transverse processes of the thoracic and lumbar vertebrae, and
the wings of the sacrum), and dorsal root ganglia from cattle 30
months of age and older (9 CFR 310.22(a)(1)). SRMs also include the
distal ileum of the small intestine and the tonsils from all cattle
(9 CFR 310.22(a)(2)).
---------------------------------------------------------------------------
Regarding poultry, the PPIA and its implementing regulations define
the term ``poultry product'' as any poultry carcass or part thereof; or
any product which is made wholly or in part from any poultry carcass or
part thereof (21 U.S.C. 453(f); 9 CFR 381.1). The term ``poultry food
product'' refers to any product capable of use as human food which is
made in part from any poultry carcass or part thereof (9 CFR 381.1).
If a new method of production or processing alters the biological,
chemical, nutritional, or organoleptic properties of meat or poultry to
the extent that the resulting product no longer aligns with consumers'
expectations, FSIS establishes new label requirements to ensure
consumers' expectations are met. For example, in 1995, FSIS evaluated
the need to establish new labeling requirements for mechanically
separated poultry (MSP) (60 FR 55962, November 3, 1995). FSIS found
that this novel method of deriving poultry products using the
mechanical separation process resulted in a product whose physical
form, texture, and ingredients, e.g., bone content, differ materially
from those of other boneless poultry products produced by hand deboning
techniques. FSIS therefore established a new standard of identity for
MSP (9 CFR 381.173) to ensure consumer expectations are met.
Conversely, in 2004, FSIS evaluated the need to establish new
labeling requirements for meat derived using advanced meat recovery
(AMR) systems (69 FR 1874, January 12, 2004). There, FSIS found that
AMR product was comparable to meat derived by hand deboning in terms of
its composition, appearance, and texture so long as it was produced in
accordance with the regulations. FSIS therefore did not need to
establish new labeling regulations for AMR products to meet consumer
expectations. Instead, the Agency set compositional criteria for AMR
products and modified the definition of ``meat'' to make it clear that
boneless meat products, such as AMR products, may not include a
significant portion of bone or related components (9 CFR 318.24).
C. FDA-FSIS Joint Agreement Regarding Oversight of Human Food Produced
Using Animal Cell Technology Derived From Cell Lines of USDA-Amenable
Species
On March 7, 2019, the Food and Drug Administration (FDA) and FSIS
signed a formal agreement to jointly oversee the production of human
food products comprised of or containing cultured cells derived from
cell lines of those species covered under the Acts.\6\ The agreement
describes each agency's intended role with respect to the oversight of
such products. In summary, FDA will oversee the collection, growth and
differentiation of livestock and poultry cells until cell harvest. A
transition from FDA to FSIS oversight will occur during the cell
harvest stage. FSIS will then oversee the processing, packaging, and
labeling of the resulting meat and poultry products made using animal
cell culture technology.
---------------------------------------------------------------------------
\6\ Formal agreement between the U.S. Department of Health and
Human Services Food and Drug Administration and U.S. Department of
Agriculture Office of Food Safety Regarding Oversight of Human Food
Produced Using Animal Cell Technology Derived from Cell Lines of
USDA-amenable Species, March 7, 2019, available at https://www.fsis.usda.gov/sites/default/files/media_file/2020-07/Formal-Agreement-FSIS-FDA.pdf.
---------------------------------------------------------------------------
FDA will continue to have the sole responsibility to regulate foods
for animals, as well as for those foods for humans comprised of or
containing cultured animal cells from species under FDA's jurisdiction,
i.e., those not amenable to the FMIA or PPIA, such as seafood species
other than Siluriformes fish.\7\ In the formal agreement, FSIS and FDA
have agreed to develop joint principles for product labeling and claims
to ensure that FDA and FSIS regulated products are labeled consistently
and transparently and work developing those principles is continuing.
On October 7, 2020, FDA published a Request for Information
[[Page 49494]]
(RFI), similar to this ANPR, soliciting comments on the labeling of
seafood products under their jurisdiction and made using animal cell
culture technology (Labeling of Foods Comprised of or Containing
Cultured Seafood Cells; Request for Information; 85 FR 63277). FSIS
will consider comments submitted in response to FDA's RFI as it
develops rules governing the labeling of cell cultured products, to the
extent they are relevant to the development of joint labeling
principles and the regulation of meat and poultry.
---------------------------------------------------------------------------
\7\ FDA also has jurisdiction over products with 3% or less raw
meat or less than 2% cooked meat or poultry meat.
---------------------------------------------------------------------------
D. United States Cattlemen's Association Petition
The United States Cattlemen's Association (USCA) filed a petition
dated February 9, 2018, with FSIS regarding the labeling of cultured
meat.\8\ The petition requests that FSIS limit the definition of
``beef'' to products derived from cattle born, raised, and harvested in
the traditional manner, and thereby prohibit foods comprised of or
containing cultured animal cells from being labeled as ``beef.'' The
petition similarly requests that FSIS limit the definition of ``meat''
to the tissue or flesh of animals that have been harvested in the
traditional manner, and thereby prohibit foods comprised of or
containing cultured animal cells from being labeled as ``meat.''
---------------------------------------------------------------------------
\8\ Petition 18-01 Submitted by the U.S. Cattlemen's
Association, February 9, 2018, available at https://www.fsis.usda.gov/federal-register/petitions/petition-limit-definition-beef-traditional-sources.
---------------------------------------------------------------------------
FSIS received over 6000 comments \9\ on the petition from trade
associations, consumer advocacy groups, businesses operating in the
meat, poultry, and cultured food product markets, and consumers. Most
comments opposed the petition overall; however, nearly all generally
agreed that cultured meat and beef should be labeled in a manner that
indicates how it was produced and differentiates it from slaughtered
meat products.
---------------------------------------------------------------------------
\9\ Public comments on Petition 18-01 are available at https://www.regulations.gov/document/FSIS-2018-0016-0001/comment.
---------------------------------------------------------------------------
Several commenters, both for and against the petition, discussed
the nature and source of cultured meat to support their arguments.
Generally, commenters in support of the petition argued that cultured
meat will not have the same characteristics as slaughtered meat or beef
and, thus, should not be marketed as such. Commenters opposed to the
petition, however, noted that cultured meat is derived from the same
species as slaughtered meat and beef and can be produced with
substantially similar characteristics as such products. Many commenters
opposed to the petition also argued that the terms ``meat'' and
``beef'' were necessary to inform consumers of the texture, shape, and
function of certain cultured meat products.
Commenters in support of the petition typically favored the
creation of a standard of identity to differentiate slaughtered meat
and beef from cultured products. Some livestock industry organizations
that opposed the petition overall, also supported the creation of a
standard of identity for cultured meat products. However, most opposed
to the petition argued that standards of identity are not warranted,
based on their assertions that cultured products, like slaughtered
products, fall within the statutory and regulatory definitions of
``meat'' or ``meat food product'' under the FMIA.
Finally, some commenters expressed concern that the petition, if
granted, would hamper innovation and, thereby, hurt the meat industry.
A few others opposed the petition contending that the regulation of
cultured meat labeling would violate the First Amendment.
E. Public Meeting on Animal Cell Culture Technology
FSIS and FDA held a joint public meeting in October 2018 to discuss
the potential hazards, oversight considerations, and labeling of
cultured food products derived from livestock and poultry tissue (83 FR
46476). The aforementioned USCA petition was also a topic of
discussion. Transcripts of the meeting are available on the FSIS
website.\10\
---------------------------------------------------------------------------
\10\ USDA and FDA Joint Public Meeting on the Use of Cell
Culture Technology to Develop Products Derived from Livestock and
Poultry, October 23-24, 2018, available at https://www.fsis.usda.gov/news-events/events-meetings/usda-and-fda-joint-public-meeting-use-cell-culture-technology-develop.
---------------------------------------------------------------------------
FSIS received approximately 315 comments on the joint public
meeting, many of which were concerned with the labeling of cultured
meat and poultry products. Comments expressed divergent views on
whether cultured meat products should be labeled ``meat.'' Many felt
the term would be misleading, arguing that cultured products are not
produced in the same manner as, nor share substantially similar
characteristics with, traditional meat. Some, however, felt it would be
misleading not to refer to cultured products as ``meat,'' arguing that
such products are derived from the same amenable livestock and can be
produced to have the same characteristics as slaughtered meat products.
Many on both sides of the issue agreed that the product name and
other information on cultured meat and poultry product labels should
indicate they were made using animal cell culture technology. Some also
asked FSIS to establish standards of identity for cultured products. A
few commenters, however, opposed such requirements, reasoning that
animal cell culture technology does not alter the basic characteristics
of the foods and that a standard of identity or other new labeling
rules would stifle innovation in the cultured foods industry. A few
comments were also concerned that new labeling requirements would
unnecessarily put cultured products at a competitive disadvantage to
slaughtered products.
Commenters were also concerned with the regulation of special
statements and claims on cell cultured products labels. Many comments
asked FSIS to subject such claims to the same prior label approval
process and oversight as slaughtered products. Others asked FSIS to
establish specific guidance for such claims to ensure they are truthful
and supported by sound science. A few advocated that animal cell
culture technology companies be allowed to make special statements and
claims about the environmental, food safety, and other benefits of
their products, so long as they provide evidence to support such
assertions.
F. Harvard Law School Animal Law & Policy Clinic Petition
FSIS also has received a petition from the Harvard Law School
Animal Law & Policy Clinic dated June 9, 2020, concerning the labeling
of products made using animal cell culture technology.\11\ The petition
requests that FSIS adopt a labeling approach for cultured meat and
poultry products that respects First Amendment commercial speech
protections. The petition specifically requests that FSIS establish a
labeling approach that does not require new standards of identity and
does not ban the use of common or usual meat or poultry terms or other
product terms specified in regulatory standards of identity. The
petition asserts that FSIS should wait until the Agency has a better
understanding of the compositional and safety characteristics of
finished products made using animal cell culture technology, and until
it has had the opportunity to review proposed labels, before
establishing speech restrictions that could raise constitutional
[[Page 49495]]
questions. To date, FSIS received one comment from a non-profit
organization, conveying broad support for the petition.
---------------------------------------------------------------------------
\11\ Petition 20-03 Submitted by Harvard Law School Animal Law &
Policy Clinic, June 9, 2020, available at https://www.fsis.usda.gov/policy/petitions/.
---------------------------------------------------------------------------
G. U.S. Government Accountability Office Report
The U.S. Government Accountability Office (GAO) recently completed
a review to, in part, understand how much information on the commercial
production of cultured meat and poultry is available to federal
regulators, including FSIS.\12\ It found that federal regulators lack
specific information on the technology being used, eventual commercial
production methods, and composition of the final products. FSIS hopes
to receive such information in response to this ANPR, so that it can
make informed decisions regarding the labeling of these products.
---------------------------------------------------------------------------
\12\ U.S. Government Accountability Office, Food Safety: FDA and
USDA Could Strengthen Existing Efforts to Prepare for Oversight of
Cell-Cultured Meat, April 2020, available at: https://www.gao.gov/products/gao-20-325.
---------------------------------------------------------------------------
II. Issues for Comment
FSIS invites comment on the issues discussed in this ANPR to help
inform future rulemaking on the labeling of products made using animal
cell-culture technology. Specifically, FSIS seeks responses to the
questions listed below. Please explain the reasoning behind your
responses in detail. Also, provide any data, studies, or other evidence
that supports your response. To help FSIS review comments efficiently,
please identify the question to which you are responding by its
associated number and letter (e.g., ``2a'') or whether you are
commenting on a topic not listed below.
1. Should the product name of a meat or poultry product
comprised of or containing cultured animal cells differentiate the
product from slaughtered meat or poultry by informing consumers the
product was made using animal cell culture technology? If yes, what
criteria should the agency consider or use to differentiate the
products? If no, why not?
2. What term(s), if any, should be in the product name of a food
comprised of or containing cultured animal cells to convey the
nature or source of the food to consumers? (e.g., ``cell cultured''
or ``cell cultivated.'')
a. How do these terms inform consumers of the nature or source
of the product?
b. What are the benefits or costs to industry and consumers
associated with these terms?
c. If meat or poultry products comprised of or containing
cultured animal cells were to be labeled with the term ``culture''
or ``cultured'' in their product names or standards of identity
(e.g., ``cell culture[d]''), would labeling differentiation be
necessary to distinguish these products from other types of foods
where the term ``culture'' or ``cultured'' is used (such as
``cultured celery powder'')?
3. If a meat or poultry product were comprised of both
slaughtered meat or poultry and cultured animal cells, what unique
labeling requirements, if any, should be required for such products?
4. What term(s), if used in the product name of a food comprised
of or containing cultured animal cells, would be potentially false
or misleading to consumers? For each term, please provide your
reasoning.
5. What term(s), if used in the product name of a food comprised
of or containing cultured animal cells, would potentially have a
negative impact on industry or consumers? For each term, please
provide your reasoning.
6. Should names for slaughtered meat and poultry products
established by common usage (e.g., Pork Loin), statute, or
regulation be included in the names or standards of identity of such
products derived from cultured animal cells?
a. If so, is additional qualifying language necessary? What
qualifying terms or phrases would be appropriate?
b. Do these names, with or without qualifying language, clearly
distinguish foods comprised of or containing cultured animal cells
from slaughtered products?
7. Should terms that specify the form of meat or poultry
products (such as ``fillet'', ``patty'', or ``steak'') be allowed to
be included in or to accompany the name or standard of identity of
foods comprised of or containing cultured animal cells?
a. Under what circumstances should these terms be used?
b. What information would these terms convey to consumers?
8. Should FSIS establish a regulatory standard of identity under
its authorities in the FMIA and the PPIA (21 U.S.C. 607(c) and
457(b)) for foods comprised of or containing cultured animal cells?
a. If so, what would be the standard and how might compliance
with the standard be verified?
b. If so, what would be the labeling terminology for products
that do and do not meet a formal standard of identity? What would be
the anticipated categories of use? For example, mechanically
separated poultry that does not meet the standards of identity
outlined in 9 CFR 381.173 may be diverted for production in broths
and bases, as well as reaction flavors, i.e., flavors produced by
the heating of the protein source in the presence of a reducing
sugar.
c. If so, what are the benefits and costs to industry if the
standard of identity is established? Please provide quantitative and
qualitative feedback in your response and explain the basis of any
quantitative estimates.
d. If so, what are the consumer benefits and costs to the
standard of identity recommended?
9. What nutritional, organoleptic (e.g., appearance, odor,
taste), biological, chemical, or other characteristics, material to
consumers' purchasing and consumption decisions, vary between
slaughtered meat or poultry products and those comprised of or
containing cultured animal cells?
10. Should any of the definitions for ``meat'', ``meat
byproduct'', or ``meat food product'' found in 9 CFR 301.2 be
amended to specifically include or exclude foods comprised of or
containing cultured animal cells?
11. Should any of the definitions for ``poultry product'' or
``poultry food product'' found in 9 CFR 381.1 be amended to
specifically include or exclude foods comprised of or containing
cultured animal cells?
12. Should FSIS-regulated broths, bases, and reaction flavors
produced from cultured animal cells be required to declare the
source material in the product name, ingredient sub-listing, or
elsewhere on the label?
13. Should the presence of cultured animal cells in further
processed products regulated by FSIS, such as a lasagna made with
cell cultured beef cells as an ingredient, be qualified on the
product label? If so, how should this be qualified?
14. What label claims are likely to appear on FSIS-regulated
products comprised of or containing cultured animal cells? Should
FSIS develop new regulations or guidance on such claims to ensure
they are neither false nor misleading?
III. Request for Economic Data and Consumer Research
Along with the above questions about the costs and benefits of
labeling options for cell cultured meat and poultry, FSIS seeks
economic data and consumer research to help increase its understanding
of the animal cell culture technology industry and related issues
regarding labeling and consumer perceptions of food made using this
technology. FSIS is particularly interested in information regarding:
(1) The impact of the labeling of cell cultured meat and poultry on
consumers' perception of and willingness to pay for cultured meat and
poultry products; (2) the expected price per pound of cultured meat and
poultry products; (for example, FSIS has reviewed recent studies that
discuss consumer perception \13\ and willingness to pay \14\ for
cultured meat products); (2) the expected price per pound of cultured
meat and poultry products; (3) the number of domestic and the number of
international animal cell culture technology companies estimated to
enter the U.S. market (for example, FSIS is aware of eight domestic
companies who belong to the Alliance for Meat, Poultry and Seafood
Innovation (AMPS
[[Page 49496]]
Innovation) trade association); (4) the expected average annual volume
per company, broken down by species or product type; (5) the expected
number of labels per company, broken down by species or product type;
(6) company size by expected revenue and number of employees; (7) data
on the consumer benefits from labels that clearly identify or
differentiate cultured meat and poultry products (e.g., saved research
costs); and (8) information on naming conventions that would discourage
consumer purchases or producer innovations and the associated economic
impact. FSIS also seeks consumer research related to labeling
nomenclature for products made using animal cell culture technology.
---------------------------------------------------------------------------
\13\ Kantor, Bella Nichole, Kantor, Jonathan. Public Attitudes
and Willingness to Pay for Cultured Meat: A Cross-Sectional
Experimental Study. Frontiers in Sustainable Food Systems. Volume 5
(2021) pg 26. Accessed on June 22, 2021: https://www.frontiersin.org/articles/10.3389/fsufs.2021.594650/full.
\14\ Rolland NCM, Markus CR, Post MJ. The Effect of Information
Content on Acceptance of Cultured Meat in a Tasting Context. PLOS
ONE 15(4): e0231176(2020) Accessed on June 22, 2021: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231176.
---------------------------------------------------------------------------
IV. Label Evaluation Prior to Rulemaking
Should any establishment wish to distribute a cultured meat or
poultry product in commerce prior to related labeling rulemaking being
completed, the establishment would need to submit the product label to
FSIS for review. To learn about the process for submitting labels to
FSIS, please see the ``Labeling and Label Approval'' web page.\15\ As
discussed above, labels for cultured product are not eligible for
generic approval at this time because neither industry nor consumers
have experience with cultured products or their labels. Therefore, FSIS
will need to review and approve cultured meat and poultry product
labels before they are used in commerce to ensure they are not false or
misleading. During label review, FSIS will ensure the labels clearly
differentiate cell cultured product from slaughtered meat and poultry
products and will ensure the labels bear all mandatory features
required by the regulations for meat and poultry products. Labels
approved for cell cultured meat and poultry products prior to the
conclusion of this rulemaking may need to be changed for compliance
with the requirements of final regulations.
---------------------------------------------------------------------------
\15\ FSIS Labeling and Label Approval web page, https://www.fsis.usda.gov/inspection/compliance-guidance/labeling.
---------------------------------------------------------------------------
V. USDA Non-Discrimination Statement
In accordance with Federal civil rights law and U.S. Department of
Agriculture (USDA) civil rights regulations and policies, the USDA, its
Agencies, offices, and employees, and institutions participating in or
administering USDA programs are prohibited from discriminating based on
race, color, national origin, religion, sex, gender identity (including
gender expression), sexual orientation, disability, age, marital
status, family/parental status, income derived from a public assistance
program, political beliefs, or reprisal or retaliation for prior civil
rights activity, in any program or activity conducted or funded by USDA
(not all bases apply to all programs). Remedies and complaint filing
deadlines vary by program or incident.
Persons with disabilities who require alternative means of
communication for program information (e.g., Braille, large print,
audiotape, American Sign Language, etc.) should contact the responsible
Agency or USDA's TARGET Center at (202) 720-2600 (voice and TTY) or
contact USDA through the Federal Relay Service at (800) 877-8339.
Additionally, program information may be made available in languages
other than English.
To file a program discrimination complaint, complete the USDA
Program Discrimination Complaint Form, AD-3027, found online at https://www.usda.gov/oascr/how-to-file-a-program-discrimination-complaint and
at any USDA office or write a letter addressed to USDA and provide in
the letter all of the information requested in the form. To request a
copy of the complaint form, call (866) 632-9992. Submit your completed
form or letter to USDA by: (1) Mail: U.S. Department of Agriculture,
Office of the Assistant Secretary for Civil Rights, 1400 Independence
Avenue SW, Washington, DC 20250-9410; (2) fax: (202) 690-7442; or (3)
email: [email protected].
USDA is an equal opportunity provider, employer, and lender.
VI. Additional Public Notification
Public awareness of all segments of rulemaking and policy
development is important. Consequently, FSIS will announce this Federal
Register publication online through the FSIS web page located at:
https://www.fsis.usda.gov/federal-register.
FSIS also will announce and provide a link to it through the FSIS
Constituent Update, which is used to provide information regarding FSIS
policies, procedures, regulations, Federal Register notices, FSIS
public meetings, and other types of information that could affect or
would be of interest to our constituents and stakeholders. The
Constituent Update is available on the FSIS web page. Through the web
page, FSIS is able to provide information to a much broader, more
diverse audience. In addition, FSIS offers an email subscription
service which provides automatic and customized access to selected food
safety news and information. This service is available at https://www.fsis.usda.gov/subscribe. Options range from recalls to export
information, regulations, directives, and notices. Customers can add or
delete subscriptions themselves and have the option to password protect
their accounts.
Paul Kiecker,
Administrator.
[FR Doc. 2021-19057 Filed 9-2-21; 8:45 am]
BILLING CODE 3410-DM-P